JLL Malaysia Expands Horizons in Medical Device Manufacturing

JLL Malaysia Sdn. Bhd., a wholly-owned subsidiary of Japan Lifeline Co., Ltd. (JLL) founded in 2017, stands as a leading player in medical device manufacturing, specialising in Electrophysiology Catheters. With a proud legacy dating back to 1981, JLL has consistently excelled in the sales and manufacturing of medical devices, including Cardiac Pacemakers, Stent-grafts, and Electrophysiology Catheters. Listed on Japan’s Prime Market, the company’s impressive net sales of JPY51.7 billion for the fiscal year ending March 2023 reflect its unwavering commitment to advancing healthcare solutions.

In a bold initiative, JLL Malaysia Sdn. Bhd. is revolutionising Malaysia’s medical device manufacturing scene. The Penang facility is currently undergoing a significant expansion, incorporating cutting-edge equipment for new product manufacturing, and expanding clean room facilities. This expansion not only generates more job opportunities but also includes plans to augment the workforce by hiring foreign workers. The company is broadening its functions, encompassing self-procurement of raw materials, introducing sterilisation processes, and refining packaging procedures. Demonstrating commitment to sustainability, solar panels will soon grace the facility, marking a pivotal step towards greener and more efficient operations in Malaysia’s industrial landscape.

The strategic decision to choose Malaysia stems from many compelling factors. The nation’s safety and also immunity to natural disasters established an ideal operational environment. The proficiency of Malaysians in English ensures seamless communication. The cost-effectiveness of local talents is a standout advantage, while the government’s focused efforts on attracting medical industry players bring preferential tax treatment and other benefits. Proximity to renowned medical device manufacturers in the region, along with established contacts in Penang State, further solidifies Malaysia’s appeal. Additionally, the nation’s pro-Japanese sentiment aligns harmoniously with our business ethos.

Navigating Malaysia’s investment landscape, JLL’s experience is shaped by strategic considerations. Capital allowances propel innovation, while investment tax incentives unlock growth opportunities. Addressing challenges and ensuring provisions for managing business losses showcase JLL’s resilience. The Green Investment Tax Allowance (GITA) application which is currently undergoing processing with MIDA reflects the company’s commitment to sustainable practices. This journey exemplifies how Malaysia’s fiscal incentives and support mechanisms assume pivotal roles in fostering a conducive environment for businesses to thrive. As JLL Malaysia expands its horizons, it not only contributes to the growth of the medical device industry but also underscores Malaysia’s status as a prime destination for innovative healthcare solutions.